Modeling hepatitis B virus X–induced hepatocellular carcinoma in mice with the sleeping beauty transposon system†
Article first published online: 3 JAN 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 53, Issue 3, pages 781–790, March 2011
How to Cite
Keng, V. W., Tschida, B. R., Bell, J. B. and Largaespada, D. A. (2011), Modeling hepatitis B virus X–induced hepatocellular carcinoma in mice with the sleeping beauty transposon system. Hepatology, 53: 781–790. doi: 10.1002/hep.24091
Potential conflict of interest: Nothing to report.
- Issue published online: 2 MAR 2011
- Article first published online: 3 JAN 2011
- Accepted manuscript online: 24 NOV 2010 11:58AM EST
- Manuscript Accepted: 11 NOV 2010
- Manuscript Received: 24 AUG 2010
- Vincent W. Keng, Barbara R. Tschida, and David A. Largaespada are supported by grant R01 CA132962 from the National Cancer Institute. Jason B. Bell is supported by grant R01 DK082516 from the National Institutes of Health
Additional Supporting Information may be found in the online version of this article.
|HEP_24091_sm_suppfigure1.tif||10510K||Proliferative and oncogenic potential of HBx in a selectively repopulating liver. (A) Transgene vectors used for hydrodynamic delivery. (B) Luciferase imaging of mice injected with either HBx (top) or Gfp (bottom) at 48-days post-hydrodynamic injection (PHI). (C) Livers injected with HBx at 74-days (left) and 139-days (right) PHI were rough in texture with hyperplastic nodules. Scale bars, 0.5 cm. (D) Representative liver of control mice injected with Gfp at 113-days PHI (left). Fluorescent imaging of a representative lobe displayed uniform Gfp signal throughout the lobe (right). Scale bar, 0.5 cm.|
|HEP_24091_sm_suppfigure2.tif||7427K||Augmented oncogenic potential of HBx with shp53 in a selectively repopulating liver. (A) Control animals coinjected with empty vector and vector containing a short hairpin RNA directed against Trp53 (shp53) (empty/shp53) were normal at 63-days PHI (left). Animals coinjected with HBx and shp53 (HBx/ shp53) had rough surface texture with nodular appearance (middle). Hyperplastic nodules were detected at 71-days PHI for HBx/ shp53 animals (right). Scale bars, 0.5 cm. (B) Fluorescent imaging of representative lobes taken from livers described in (A) for Gfp signal. Empty/shp53 liver lobe had uniform Gfp signal (left). However, liver lobes taken from HBx/ shp53 animals at 63- and 71-days PHI had nodular Gfp signals (middle and right, respectively). (C) RT-PCR analyses of various genes-of-interest in macroscopically normal liver and hyperplastic nodules taken from 72-days PHI HBx/ shp53 experimental mice (n = 3). Dashed lines separate different mouse sample groups. (D) Semi-quantitative analysis of RT-PCR from (D) demonstrated significantly higher Afp expression levels in (i) normal HBx/ shp53 (8 livers from 3 animals) compared with normal empty/shp53 (15 livers from 5 animals) livers (P = 0.0035) and (ii) hyperplastic HBx/ shp53 nodules (7 nodules from 2 animals) compared with normal empty/shp53 livers (P < 0.0001). No statistical difference in Afp expression relative to Actb levels was seen between normal liver and hyperplastic nodules isolated from HBx/ shp53 animals (P = 0.3818). RT-PCR for Afp expression levels in normal empty/ shp53 livers data not shown. P, unpaired t test.|
|HEP_24091_sm_suppfigure3.tif||7193K||NRAS does not cooperate with HBx in liver tumorigenesis during selective repopulation. (A) NRAS induced hyperplasia at 82-days PHI (left) and its oncogenic potential was augmented by the detection of hyperplastic nodules in all experimental animals at 71-days PHI when coinjected with shp53 (NRAS/shp53) (middle). In contrast, only 1 hyperplastic nodule was detected in animals coinjected with HBx and NRAS (HBx/ NRAS) at 72-days PHI (right). Scale bars, 0.5 cm. (B) When HBx, NRAS and shp53 were coinjected (HBx/ NRAS/ shp53), mice sacrificed at 61- and 71-days PHI had multiple hyperplastic nodules detected (left and right, respectively). Scale bars, 0.5 cm. (C) Fluorescent imaging of representative lobes taken from livers described in (A) and (B) for Gfp signal. Lobes taken from HBx/ shp53 animals or HBx/ NRAS/ shp53 had nodular Gfp signals (left and right, respectively). (D) RT-PCR analyses of various genes-of-interest in normal livers and hyperplastic nodules taken from HBx/ NRAS/ shp53 and NRAS/ shp53 mice sacrificed at 61-days PHI.|
|HEP_24091_sm_suppfigure4.tif||11108K||Detection of CD45+ lymphocyte infiltration into livers of various transgene injected mice by immunohistochemical analysis. HBx, 78-day PHI; HBx/ shp53, 72-day PHI; HBx/ NRAS, 72-day PHI; NRAS/ shp53, 61-day PHI; NRAS, 82-day PHI; Gfp, 113-day PHI. Left column, sections were incubated with anti-CD45. Right column, no primary antibody was used. Scale bars, 100 μm.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.